{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:23Z","timestamp":1786979963894,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00296-012-2489-y","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T06:25:44Z","timestamp":1343197544000},"page":"965-971","source":"Crossref","is-referenced-by-count":64,"title":["The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis"],"prefix":"10.1007","volume":"33","author":[{"given":"Vidya","family":"Limaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Luke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Blumbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Roberts-Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"issue":"1","key":"2489_CR1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/bjoc.2001.1699","volume":"85","author":"D Stockton","year":"2001","unstructured":"Stockton D, Doherty VR, Brewster DH (2001) Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85(1):41\u201345","journal-title":"Br J Cancer"},{"key":"2489_CR2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","volume":"134","author":"R Buchbinder","year":"2001","unstructured":"Buchbinder R, Forbes A, Hall S et al (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy: a population-based cohort study. Ann Intern Med 134:1087\u20131095","journal-title":"Ann Intern Med"},{"key":"2489_CR3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","volume":"357","author":"CL Hill","year":"2001","unstructured":"Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96\u2013100","journal-title":"Lancet"},{"key":"2489_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00051675","volume":"6","author":"WH Chow","year":"1995","unstructured":"Chow WH, Gridley G, Mellemkjaer L, McLaughlin JK, Olsen JH, Fraumeni JF Jr (1995) Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 6:9\u201313","journal-title":"Cancer Causes Control"},{"issue":"6","key":"2489_CR5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/BOR.0b013e3283317fa5","volume":"21","author":"K Dank\u00f3","year":"2009","unstructured":"Dank\u00f3 K, Ponyi A, Molnar AP, Andr\u00e1s C, Constantin T (2009) Paraneoplastic myopathy. Curr Opin Rheumatol 21(6):594\u2013598","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"2489_CR6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","volume":"201","author":"L Casciola-Rosen","year":"2005","unstructured":"Casciola-Rosen L, Nagaraju K, Plotz P, Wang K, Levine S, Gabrielson E et al (2005) Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy. J Exp Med 201(4):591\u2013601","journal-title":"J Exp Med"},{"issue":"6","key":"2489_CR7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.bor.0000245721.02512.77","volume":"18","author":"SM Levine","year":"2006","unstructured":"Levine SM (2006) Cancer and myositis: new insights into an old association. Curr Opin Rheumatol 18(6):620\u2013624","journal-title":"Curr Opin Rheumatol"},{"key":"2489_CR8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/archotol.1995.01890110072013","volume":"121","author":"JC Peng","year":"1995","unstructured":"Peng JC, Sheen TS, Hsu MM (1995) Nasopharyngeal carcinoma with dermatomyositis: analysis of 12 cases. Arch Otolaryngol Head Neck Surg 121:1298\u20131301","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2489_CR9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-4362.1985.tb05520.x","volume":"24","author":"HL Chan","year":"1985","unstructured":"Chan HL (1985) Dermatomyositis and cancer in Singapore. Int J Dermatol 24:447\u2013450","journal-title":"Int J Dermatol"},{"key":"2489_CR10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","volume":"144","author":"YJ Chen","year":"2001","unstructured":"Chen YJ, Wu CY, Shen JL (2001) Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol 144:825\u2013831","journal-title":"Br J Dermatol"},{"key":"2489_CR11","first-page":"1300","volume":"22","author":"A Airo","year":"1995","unstructured":"Airo A, Pukkala E, Isomaki H (1995) Elevated cancer incidence in patients with dermatomyositis: a population-based study. J Rheumatol 22:1300\u20131303","journal-title":"J Rheumatol"},{"key":"2489_CR12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"326","author":"B Sigurgeirsson","year":"1992","unstructured":"Sigurgeirsson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326:363\u2013367","journal-title":"N Engl J Med"},{"issue":"7","key":"2489_CR13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan Bohan","year":"1975","unstructured":"Bohan Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347","journal-title":"N Engl J Med"},{"key":"2489_CR14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1999","unstructured":"Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH et al (1999) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 70:360\u2013374","journal-title":"Medicine"},{"issue":"4","key":"2489_CR15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Sen\u00e9cal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84(4):231\u2013249","journal-title":"Medicine (Baltimore)"},{"key":"2489_CR16","doi-asserted-by":"crossref","first-page":"116S","DOI":"10.1038\/jid.1993.34","volume":"100","author":"IN Targoff","year":"1993","unstructured":"Targoff IN (1993) Humoral immunity in polymyositis\/dermatomyositis. J Invest Dermatol 100:116S\u2013123S","journal-title":"J Invest Dermatol"},{"key":"2489_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","volume":"39","author":"A Ghirardello","year":"2006","unstructured":"Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C et al (2006) Clinical implications of autoantibody screening in patients with autoimmune myositis. Autoimmunity 39:217\u2013221","journal-title":"Autoimmunity"},{"issue":"4","key":"2489_CR18","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","volume":"9","author":"M Koenig","year":"2007","unstructured":"Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Sen\u00e9cal JL (2007) Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 9(4):R78","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"2489_CR19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/BOR.0b013e328313bff4","volume":"20","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, Betteridge ZE, McHugh NJ (2008) Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol 20(6):675\u2013680","journal-title":"Curr Opin Rheumatol"},{"key":"2489_CR20","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","volume":"66","author":"H Chinoy","year":"2007","unstructured":"Chinoy H, Fertig N, Oddis CV, Ollier WER, Cooper RG (2007) The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 66:1345\u20131349","journal-title":"Ann Rheum Dis"},{"key":"2489_CR21","doi-asserted-by":"crossref","unstructured":"Limaye V, Hakendorf P, Woodman RJ, Blumbergs P, Roberts-Thomson P (2010) Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis. Int Med J. doi: 10.1111\/j.1445-5994.2010.02406.x","DOI":"10.1111\/j.1445-5994.2010.02406.x"},{"issue":"1","key":"2489_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","volume":"89","author":"E Trallero-Aragu\u00e1s","year":"2010","unstructured":"Trallero-Aragu\u00e1s E, Labrador-Horrillo M, Selva-O\u2019Callaghan A, Mart\u00ednez MA, Mart\u00ednez-G\u00f3mez X, Palou E et al (2010) Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore) 89(1):47\u201352","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2489_CR23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","volume":"85","author":"TP O\u2019Hanlon","year":"2006","unstructured":"O\u2019Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M et al (2006) Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 85(2):111\u2013127","journal-title":"Medicine (Baltimore)"},{"key":"2489_CR24","first-page":"221","volume-title":"Structural and molecular basis of skeletal muscle diseases","author":"R Hohlfeld","year":"2002","unstructured":"Hohlfeld R (2002) Polymyositis and dermatomyositis. In: Karpati G (ed) Structural and molecular basis of skeletal muscle diseases. ISN Neuropath Press, Switzerland, pp 221\u2013227"},{"key":"2489_CR25","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/j.lpm.2011.01.005","volume":"40","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC (2011) Pathophysiology of inflammatory and autoimmune myopathies. Presse Med 40:e237\u2013e247","journal-title":"Presse Med"},{"key":"2489_CR26","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","volume":"70","author":"N Chahin","year":"2008","unstructured":"Chahin N, Engel AG (2008) Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology 70:418\u2013424","journal-title":"Neurology"},{"key":"2489_CR27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"FL Mastaglia","year":"2002","unstructured":"Mastaglia FL, Philips VA (2002) Idiopathic inflammatory myopathies, epidemiology, classification and diagnostic criteria. Rheum Dis Clin North Am 28:723\u2013741","journal-title":"Rheum Dis Clin North Am"},{"key":"2489_CR28","unstructured":"NE Breslow, NE Day Statistical methods in cancer research: vol II\u2013The design and analysis of cohort studies. IARC Scientific Publications (International Agency for Research on Cancer), pp 49\u201351"},{"key":"2489_CR29","doi-asserted-by":"crossref","unstructured":"Limaye VS, Lester S, Bardy P, Thompson P, Cox S, Blumbergs P, Roberts-Thomson P (2012) A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis. Rheumatol Int 32(3):611\u2013619","DOI":"10.1007\/s00296-010-1637-5"},{"key":"2489_CR30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-002-0087-9","volume":"4","author":"R Buchbinder","year":"2002","unstructured":"Buchbinder R, Hill CL (2002) Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep 4:415\u2013426","journal-title":"Curr Rheumatol Rep"},{"key":"2489_CR31","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/ar2987","volume":"12","author":"YJ Chen","year":"2010","unstructured":"Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL, Chang YT (2010) Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther 12:R70","journal-title":"Arthritis Res Ther"},{"key":"2489_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0049-0172(98)80052-8","volume":"27","author":"CR Maoz","year":"1998","unstructured":"Maoz CR, Langevitz P, Livneh A, Blumstein Z, Sadeh M, Bank I et al (1998) High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum 27:319\u2013324","journal-title":"Semin Arthritis Rheum"},{"key":"2489_CR33","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.3899\/jrheum.090549","volume":"36","author":"BB Antiochos","year":"2009","unstructured":"Antiochos BB, Brown LA, Li Z, Tosteson TD, Wortmann RL, Rigby WFC (2009) Malignancy is associated with dermatomyositis but not polymyositis in Northern New England. USA J Rheumatol 36:2704\u20132710","journal-title":"USA J Rheumatol"},{"issue":"2","key":"2489_CR34","first-page":"77","volume":"13","author":"W Zhang","year":"2009","unstructured":"Zhang W, Jiang SP, Huang L (2009) Dermatomyositis and malignancy: a retrospective study of 115 cases. Eur Rev Med Pharmacol Sci 13(2):77\u201380","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2489_CR35","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0025-6196(12)62030-8","volume":"61","author":"S Lakhanpal","year":"1986","unstructured":"Lakhanpal S, Bunch TW, Ilstrup DM, Melton LJ 3rd (1986) Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc 61:645\u2013653","journal-title":"Mayo Clin Proc"},{"key":"2489_CR36","first-page":"438","volume":"35","author":"C Andras","year":"2008","unstructured":"Andras C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P et al (2008) Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35:438\u2013444","journal-title":"J Rheumatol"},{"issue":"5","key":"2489_CR37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000154149","volume":"43","author":"P Barona","year":"1993","unstructured":"Barona P, Sierrasesumaga L, Antillon F, Villa-Elizaga I (1993) Study of HLA antigens in patients with osteosarcoma. Hum Hered 43(5):311\u2013314","journal-title":"Hum Hered"},{"issue":"1","key":"2489_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000214870","volume":"4","author":"J Abrahamova","year":"1981","unstructured":"Abrahamova J, Majsky A, Koutecky J (1981) HLA-antigens in germ cell tumours of various sites. Onkologie 4(1):19\u201320","journal-title":"Onkologie"},{"issue":"4","key":"2489_CR39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/02841867809127930","volume":"17","author":"B Hornmark-Stenstam","year":"1978","unstructured":"Hornmark-Stenstam B, Landberg T, Low B (1978) HLA antigens in Hodgkin\u2019s disease of very long survival. Acta Radiol Oncol Radiat Phys Biol 17(4):283\u2013288","journal-title":"Acta Radiol Oncol Radiat Phys Biol"},{"issue":"4","key":"2489_CR40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/jso.2930360407","volume":"36","author":"SM Paul","year":"1987","unstructured":"Paul SM, Bacharach B, Goepp C (1987) A genetic influence on alveolar cell carcinoma. J Surg Oncol 36(4):249\u2013252","journal-title":"J Surg Oncol"},{"issue":"2","key":"2489_CR41","first-page":"121","volume":"6","author":"MT Illeni","year":"1985","unstructured":"Illeni MT, Pasquali M, La Monica G, Bohm S, Rovini D, Di Re E (1985) HLA antigens in ovarian adenocarcinoma patients. Eur J Gynaecol Oncol 6(2):121\u2013125","journal-title":"Eur J Gynaecol Oncol"},{"issue":"8","key":"2489_CR42","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1200\/JCO.2002.08.072","volume":"20","author":"JA Sosman","year":"2002","unstructured":"Sosman JA, Unger JM, Liu PY, Flaherty LE, Park MS, Kempf RA et al (2002) Southwest oncology group. Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumour vaccine: impact of HLA Class I antigen expression on outcome. J Clin Oncol 20(8):2067\u20132075","journal-title":"J Clin Oncol"},{"issue":"4","key":"2489_CR43","first-page":"826","volume":"56","author":"HJ Luboldt","year":"1996","unstructured":"Luboldt HJ, Kubens BS, Rubben H, Grosse-Wilde H (1996) Selective loss of human leukocyte antigen class I allele expression in advanced renal cell carcinoma. Cancer Res 56(4):826\u2013830","journal-title":"Cancer Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2489-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2489-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:21:40Z","timestamp":1559028100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2489-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["2489"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2489-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,26]]}}}